BENAROYA RESEARCH INSTITUTE – Seattle, WA – Benaroya Research Institute at Virginia Mason (BRI) is an internationally-recognized non-profit medical research institute affiliated with the Virginia Mason Health System. BRI works to advance the science that will predict, prevent, reverse and cure diseases of the immune system, to achieve its vision of a healthy immune system for every individual. Our scientific approach is to discover, translate, integrate and intervene – accelerating translation of today’s lab discoveries… into tomorrow’s clinical interventions. The institute’s core values of persistent inquiry; innovation and agility; collaboration; and integrity and respect are foundational to our work. A leader of collaborative initiatives such as the Immune Tolerance Network and Type 1 Diabetes TrialNet, BRI frequently partners with global research institutes, pharmaceutical and biotech companies to translate discoveries into clinical therapies. Visit BenaroyaResearch.org or follow BRI’s Autoimmune Life Blog, Facebook, Instagram…